Accredited Investors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $372K | Sell |
918
-7
| -0.8% | -$2.84K | 0.02% | 163 |
|
|
2025
Q1 | $460K | Sell |
925
-33
| -3% | -$16.4K | 0.03% | 132 |
|
|
2024
Q4 | $498K | Sell |
958
-23
| -2% | -$12K | 0.03% | 131 |
|
|
2024
Q3 | $607K | Buy |
981
+75
| +8% | +$46.4K | 0.03% | 120 |
|
|
2024
Q2 | $501K | Hold |
906
| – | – | 0.03% | 122 |
|
|
2024
Q1 | $527K | Buy |
906
+70
| +8% | +$40.7K | 0.03% | 123 |
|
|
2023
Q4 | $444K | Hold |
836
| – | – | 0.03% | 128 |
|
|
2023
Q3 | $423K | Hold |
836
| – | – | 0.03% | 123 |
|
|
2023
Q2 | $436K | Hold |
836
| – | – | 0.03% | 122 |
|
|
2023
Q1 | $482K | Sell |
836
-4
| -0.5% | -$2.31K | 0.04% | 114 |
|
|
2022
Q4 | $463K | Sell |
840
-8
| -0.9% | -$4.41K | 0.04% | 108 |
|
|
2022
Q3 | $430K | Buy |
848
+2
| +0.2% | +$1.01K | 0.05% | 105 |
|
|
2022
Q2 | $460K | Sell |
846
-7
| -0.8% | -$3.81K | 0.05% | 103 |
|
|
2022
Q1 | $504K | Sell |
853
-59
| -6% | -$34.9K | 0.05% | 111 |
|
|
2021
Q4 | $609K | Buy |
+912
| New | +$609K | 0.05% | 99 |
|
|
2020
Q2 | – | Sell |
-895
| Closed | -$254K | – | 140 |
|
|
2020
Q1 | $254K | Sell |
895
-176
| -16% | -$49.9K | 0.06% | 111 |
|
|
2019
Q4 | $348K | Buy |
1,071
+176
| +20% | +$57.2K | 0.06% | 103 |
|
|
2019
Q3 | $261K | Sell |
895
-264
| -23% | -$77K | 0.05% | 115 |
|
|
2019
Q2 | $340K | Hold |
1,159
| – | – | 0.07% | 103 |
|
|
2019
Q1 | $317K | Hold |
1,159
| – | – | 0.06% | 104 |
|
|
2018
Q4 | $259K | Hold |
1,159
| – | – | 0.06% | 103 |
|
|
2018
Q3 | $283K | Buy |
+1,159
| New | +$283K | 0.07% | 99 |
|